Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation
G Vanella, S Crippa, L Archibugi… - Journal of British …, 2018 - academic.oup.com
Background Although consensus guidelines suggest that patients with high-risk intraductal
papillary mucinous neoplasms (IPMNs) should have surgery, a non-operative strategy is …
papillary mucinous neoplasms (IPMNs) should have surgery, a non-operative strategy is …
Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis
I Pergolini, S Schorn, C Jäger, R Göß, A Novotny… - Surgery, 2021 - Elsevier
Background Our current knowledge of diabetes mellitus in intraductal papillary mucinous
neoplasm is very limited and its prevalence and predictive value for malignant …
neoplasm is very limited and its prevalence and predictive value for malignant …
Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome
SJ Lekkerkerker, MG Besselink, OR Busch… - Gastrointestinal …, 2017 - Elsevier
Background and Aims Currently, 3 guidelines are available for the management of
pancreatic cysts. These guidelines vary in their indication for resection of high-risk cysts. We …
pancreatic cysts. These guidelines vary in their indication for resection of high-risk cysts. We …
Should patients with cystic lesions of the pancreas undergo long-term radiographic surveillance?: results of 3024 patients evaluated at a single institution
SA Lawrence, MA Attiyeh, K Seier, M Gönen… - Annals of …, 2017 - journals.lww.com
Objective: In 2015, the American Gastroenterological Association recommended the
discontinuation of radiographic surveillance after 5 years for patients with stable pancreatic …
discontinuation of radiographic surveillance after 5 years for patients with stable pancreatic …
Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective
Background Detection of cystic lesions of the pancreas has outpaced our ability to stratify
low-grade cystic lesions from those at greater risk for pancreatic cancer, raising a concern …
low-grade cystic lesions from those at greater risk for pancreatic cancer, raising a concern …
Intraductal papillary mucinous neoplasms of the pancreas and European guidelines: importance of the surgery type in the decision-making process
E Buscail, T Cauvin, B Fernandez, C Buscail, M Marty… - BMC surgery, 2019 - Springer
Abstract Background The European Consensus 2018 established a new algorithm with
absolute and relative criteria for intraductal papillary mucinous neoplasms of the pancreas …
absolute and relative criteria for intraductal papillary mucinous neoplasms of the pancreas …
Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas
B Bournet, A Vignolle-Vidoni, D Grand… - Endoscopy …, 2016 - thieme-connect.com
Background: KRAS and GNAS mutations are common in intraductal papillary mucinous
neoplasia of the pancreas (IPMN). The aims of this study were to assess the role of pre …
neoplasia of the pancreas (IPMN). The aims of this study were to assess the role of pre …
Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary …
H Hayakawa, M Fukasawa, T Sato, S Takano… - Journal of …, 2019 - Springer
Background The present study aimed to determine the ability of diagnosing malignancy and
predicting malignant transformation in patients with IPMN using carcinoembryonic antigen …
predicting malignant transformation in patients with IPMN using carcinoembryonic antigen …
Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case-vignette study
L Scholten, NCM van Huijgevoort, MJ Bruno… - Surgery, 2018 - Elsevier
Background The risk of invasive cancer in resected intraductal papillary mucinous neoplasm
with main pancreatic duct involvement is 33%–60%. Most guidelines, therefore, advise …
with main pancreatic duct involvement is 33%–60%. Most guidelines, therefore, advise …
Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous …
KA Tulla, AV Maker - Langenbeck's archives of surgery, 2018 - Springer
Purpose Predicting the biologic behavior of intraductal papillary mucinous neoplasm (IPMN)
remains challenging. Current guidelines utilize patient symptoms and imaging …
remains challenging. Current guidelines utilize patient symptoms and imaging …